Literature DB >> 6466164

Onset of multiple sclerosis in a 24-month-old child.

J M Bejar, D K Ziegler.   

Abstract

A child, aged 24 months, incurred an episode of ataxic gait. Two months later, she had a recurrent episode of ataxic gait and bilateral blindness. Her symptoms were resolved with steroid therapy. A permanent visual deficit of 20/200 remained in the right eye. When she reached 16 years 10 months of age, she incurred the second episode of bilateral blindness. One month later, she had grand mal seizures. Her myelin basic protein level was elevated. Visual evoked responses were abnormal bilaterally. The combination of cerebellar, cortical, and eye symptoms, with a history of well-defined remissions, allowed the diagnosis of multiple sclerosis (MS) to be made. This is the youngest known patient with MS yet described, with the first attack occurring at 24 months of age.

Entities:  

Mesh:

Year:  1984        PMID: 6466164     DOI: 10.1001/archneur.1984.04050190087021

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  4 in total

1.  Hemiballismus revealing multiple sclerosis in an infant.

Authors:  M Giroud; D Semama; L Pradeaux; J B Gouyon; R Dumas; J L Nivelon
Journal:  Childs Nerv Syst       Date:  1990-06       Impact factor: 1.475

2.  Deep sylvian meningioma in a child.

Authors:  B K Cho; K C Wang; K H Chang; J G Chi
Journal:  Childs Nerv Syst       Date:  1990-06       Impact factor: 1.475

3.  Does early-onset multiple sclerosis differ from adult-onset form in Iranian people.

Authors:  Fereshteh Ashtari; Vahid Shaygannejad; Ziba Farajzadegan; Ali Amin
Journal:  J Res Med Sci       Date:  2010-03       Impact factor: 1.852

4.  The neonatal CNS is not conducive for encephalitogenic Th1 T cells and B cells during experimental autoimmune encephalomyelitis.

Authors:  Petra D Cravens; Bernd C Kieseier; Rehana Hussain; Emily Herndon; Benjamine Arellano; Li-Hong Ben; Brenda C Timmons; Cyd Castro-Rojas; Hans-Peter Hartung; Bernhard Hemmer; Martin S Weber; Scott S Zamvil; Olaf Stüve
Journal:  J Neuroinflammation       Date:  2013-05-24       Impact factor: 8.322

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.